Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05410678Phase 4Completed
Phase 4, open-label trial (2 arms), sponsored by Bursa Yuksek Ihtisas Training and Research Hospital. Primary endpoints: Major Adverse Cardiac Events at 2 years, Myocardial Infarction at 2 years and 1 more. Started Jun 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05410678.